3M Company — Q1 2015 Form 10-Q
Business context and period: Diversified global manufacturer reporting the three months ended March 31, 2015, compared with Q1 2014. Operations span Industrial, Safety and Graphics, Electronics and Energy, Health Care, and Consumer. Management described mixed global growth and a challenging currency environment. Interim financial statements are unaudited; the independent accountant performed a review, not an audit.
Key financial metrics
| Metric | Q1 2015 | Q1 2014 / comparison |
|---|---|---|
| Net sales | $7.578 billion | $7.831 billion; down 3.2% |
| Organic local-currency sales growth | 3.3% | Volume +2.3%; price +1.0% |
| Operating income | $1.730 billion | $1.716 billion; up 0.8% |
| Operating margin | 22.8% | 21.9%; up 0.9 percentage points |
| Net income attributable to 3M | $1.199 billion | $1.207 billion |
| Diluted EPS | $1.85 | $1.79 |
| Operating cash flow | $1.080 billion | $1.092 billion |
| Capital expenditures | $291 million | $293 million |
| Free cash flow (company-defined, non-GAAP) | $789 million; 66% conversion | $799 million; 66% conversion |
| Total debt / net debt | $6.591 billion / $3.769 billion | Net debt $3.486 billion at year-end 2014 |
| Cash, cash equivalents and marketable securities | $2.822 billion | $3.351 billion at year-end 2014 |
| Working capital | $7.436 billion | $5.767 billion at year-end 2014 |
| Effective tax rate | 29.5% | 27.4% |
| Cash dividends per share | $1.025 | $0.855 |
Changes versus prior period
- Foreign currency translation reduced worldwide sales by 6.5%; reported sales fell despite 3.3% organic local-currency growth across all five segments. Currency effects, including hedging, reduced pretax income by an estimated $90 million.
- Margin expansion reflected pricing, lower raw-material costs, organic-volume leverage and productivity. Higher pension and postretirement expense, strategic investments and first-year acquisition dilution partly offset these gains.
- Diluted EPS rose despite slightly lower net income, helped by a 3.7% reduction in weighted-average diluted shares. Share repurchases were $886 million versus $1.708 billion in Q1 2014.
- Segment sales in reported dollars were down in Industrial (4.3%), Safety and Graphics (3.6%), Health Care (3.3%) and Consumer (2.9%); Electronics and Energy rose 0.8%. Electronics and Energy operating income increased 24.3%, while Health Care operating income declined 4.3%.
- Net debt increased $283 million from year-end, primarily as cash and securities declined; total debt decreased $246 million, mainly due to foreign-exchange effects on foreign-currency debt.
Outlook, management commentary and risks
- Management raised its estimated 2015 effective tax-rate range to 28.5%–29.5% from 28.0%–29.0%, assuming reinstatement of the U.S. R&D tax credit.
- Expected 2015 capital spending: $1.4–$1.6 billion. Expected global pension and postretirement contributions: approximately $200 million; expected 2015 benefit expense approximately $210 million higher pretax than 2014, before curtailments and similar items.
- Management expected 2015 gross share repurchases of $3–$5 billion; $5.9 billion remained under the $12 billion authorization at quarter-end. The revolving credit facility was undrawn; the company reported an approximately 63:1 EBITDA-to-interest ratio against a 3.0:1 minimum covenant.
- 3M announced a proposed approximately $1.0 billion acquisition of Polypore’s Separations Media business, subject to regulatory approvals and customary closing conditions. It acquired Ivera Medical for $150 million net of cash acquired and sold its static-control business in January.
- Key exposures include currency movements, uneven global demand, raw-material availability and pricing, competition, acquisition integration, pension costs, cybersecurity and ERP implementation, and legal, environmental and regulatory matters.
- Contingencies include respirator/asbestos claims: $144 million accrued for 3M’s liabilities (excluding Aearo), with $41 million of related insurance receivables; the company could not estimate the upper end of possible losses. Environmental liabilities totaled $68 million across remediation and other environmental matters, with $26 million of related insurance receivables.
- Other notable litigation includes the TransWeb patent/antitrust judgment of approximately $26 million, which 3M appealed and for which it recorded no liability because it considered a loss not probable and estimable; and an EDF product dispute in France involving an expert estimate of damages exceeding €100 million, not a final court determination.
- 3M continued consolidating its Venezuelan subsidiary and reported no material consolidated impact from exchange-rate changes to date; further exchange restrictions or operating constraints could affect that assessment. The filing also notes possible future environmental and PFC-related regulatory actions.
Most important facts for investors to verify
- Whether organic growth and margin gains can persist if currency headwinds remain significant, and how the longer-dated currency hedges affect later periods.
- Execution and financing of the proposed Polypore transaction, alongside planned capital spending, dividends and $3–$5 billion of 2015 repurchases.
- Actual 2015 tax rate versus guidance, including whether the assumed U.S. R&D credit is reinstated.
- Progression of pension expense and contributions, and the effects of Japan’s plan modification and other actuarial assumptions.
- Developments in asbestos, environmental/PFC, TransWeb and product-liability matters, including changes to accruals, insurance recoveries or estimated exposure.
- Cash generation, working-capital movements, debt levels and credit ratings; Moody’s outlook was negative while S&P’s was stable.